Hydromer, Inc. has established a commercial partnership with Avem Market Solutions to expand distribution and technical support for its medical coating technologies throughout Europe and the United Kingdom. This collaboration connects Hydromer's specialized surface modification expertise with Avem's regional market knowledge and network of medical technology manufacturers.
The partnership addresses growing demands from European and UK medical device companies facing regulatory pressures while needing to accelerate innovation cycles. Through this alliance, device developers gain direct access to Hydromer's hydrophilic, lubricious, antimicrobial, and thrombo-resistant coating platforms. These technologies have been integrated into interventional, surgical, and diagnostic devices used globally for decades.
Avem will serve as Hydromer's strategic representative in the region, providing localized commercial guidance from teams deeply embedded in European and UK medical technology ecosystems. The collaboration offers medical device manufacturers earlier visibility into validated coating options, hands-on support for feasibility studies, and assistance with scale-up processes. This unified approach aims to help developers reduce time to market while enhancing device performance.
The partnership combines Hydromer's technical capabilities in custom formulation, research and development support, and scalable coating equipment design with Avem's specialized market development services. Medical technology companies can now access these resources through a single channel, streamlining the transition from prototype development to full-scale manufacturing. This eliminates traditional barriers that often complicate the adoption of advanced coating solutions.
European medical device manufacturers operating under strict regulatory frameworks benefit from having reliable access to coating technologies already proven in global markets. The partnership provides a direct resource for navigating both technical and operational challenges associated with surface modification technologies. This is particularly valuable for companies developing next-generation medical devices that require sophisticated coating solutions to meet performance and safety standards.
The collaboration represents a strategic response to the medical technology industry's need for integrated solutions that combine scientific expertise with commercial accessibility. By making advanced coating technologies more readily available and easier to implement, the partnership supports innovation across multiple medical device categories while helping manufacturers maintain compliance with evolving regulatory requirements. Additional information about the companies can be found at https://www.hydromer.com and through industry resources.
